Total Payments
$3,134
2021 Payments
$717.71
Companies
25
Transactions
232
Medicare Patients
590
Medicare Billing
$40,155
Payment Breakdown by Category
Food & Beverage$3,134 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,134 | 232 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ortho Dermatologics, a division of Bausch Health US, LLC | $520.24 | 46 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $366.18 | 26 | $0 (2021) |
| PFIZER INC. | $354.45 | 31 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $330.69 | 23 | $0 (2021) |
| Galderma Laboratories, L.P. | $224.55 | 16 | $0 (2020) |
| Lilly USA, LLC | $216.82 | 16 | $0 (2021) |
| Janssen Biotech, Inc. | $215.85 | 13 | $0 (2021) |
| AbbVie Inc. | $162.31 | 12 | $0 (2021) |
| DERMIRA, INC. | $80.34 | 6 | $0 (2020) |
| UCB, Inc. | $73.20 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $717.71 | 54 | Ortho Dermatologics, a division of Bausch Health US, LLC ($149.07) |
| 2020 | $705.51 | 49 | Sun Pharmaceutical Industries Inc. ($146.13) |
| 2019 | $993.88 | 78 | Ortho Dermatologics, a division of Bausch Health US, LLC ($181.00) |
| 2018 | $716.71 | 51 | PFIZER INC. ($106.33) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Dermatology | ||||||
| 09/14/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Dermatology | ||||||
| 09/14/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: Dermatology | ||||||
| 08/25/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Treatment of Rosacea | ||||||
| 08/23/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Dermatology | ||||||
| 08/10/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DERMATOLOGY | ||||||
| 08/09/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Dermatology | ||||||
| 08/09/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Dermatology | ||||||
| 08/06/2021 | EPI Health, LLC | CLODERM (Drug), MINOLIRA EXTENDED RELEASE, WYNZORA | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: DERMATOLOGY | ||||||
| 08/03/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Dermatology | ||||||
| 07/28/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 07/20/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Absorica LD (Drug), Ultravate | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Dermatology | ||||||
| 07/19/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Treatment of Rosacea | ||||||
| 07/14/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Dermatology | ||||||
| 07/13/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Immunology | ||||||
| 06/28/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/22/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Dermatology | ||||||
| 06/21/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Treatment of Rosacea | ||||||
| 06/18/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $11.54 | General |
| 06/09/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 06/08/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Dermatology | ||||||
| 05/25/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2021 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 311 | 523 | $52,641 | $20,176 |
| 2020 | 8 | 279 | 403 | $51,630 | $19,979 |
Total Patients
590
Total Services
926
Medicare Billing
$40,155
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 146 | $21,170 | $9,010 | 42.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $10,500 | $3,437 | 32.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 47 | 59 | $7,670 | $2,500 | 32.6% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 17 | 20 | $4,900 | $1,987 | 40.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 14 | 14 | $2,800 | $1,116 | 39.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 35 | 163 | $2,292 | $830.37 | 36.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 17 | $1,530 | $718.06 | 46.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $1,650 | $531.68 | 32.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 14 | 43 | $129.00 | $44.39 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 80 | $17,200 | $6,624 | 38.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 62 | 78 | $11,310 | $4,485 | 39.7% |
| 17000 | Destruction of skin growth | Office | 2020 | 41 | 49 | $6,370 | $2,311 | 36.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $4,620 | $1,718 | 37.2% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2020 | 17 | 20 | $4,900 | $1,712 | 34.9% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 23 | 23 | $3,450 | $1,297 | 37.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 12 | 13 | $2,600 | $1,218 | 46.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 31 | 118 | $1,180 | $614.13 | 52.0% |
About Dr. Michael Bilkis, M.D
Dr. Michael Bilkis, M.D is a Procedural Dermatology healthcare provider based in Verona, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235166349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bilkis, M.D has received a total of $3,134 in payments from pharmaceutical and medical device companies, with $717.71 received in 2021. These payments were reported across 232 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,134).
As a Medicare-enrolled provider, Bilkis has provided services to 590 Medicare beneficiaries, totaling 926 services with total Medicare billing of $40,155. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Verona, NJ
- Active Since 06/26/2006
- Last Updated 07/03/2008
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1235166349
Products in Payments
- COSENTYX (Biological) $366.18
- EUCRISA (Drug) $354.45
- DUOBRII (Drug) $263.23
- TALTZ (Drug) $216.82
- SILIQ (Drug) $148.38
- ILUMYA (Biological) $143.99
- EPIDUO FORTE (Drug) $137.18
- Ilumya (Biological) $115.60
- Tremfya (Drug) $112.88
- Otezla (Drug) $87.38
- DUPIXENT (Biological) $82.85
- Cimzia (Drug) $73.20
- TREMFYA (Drug) $62.61
- DORYX (Drug) $59.92
- PRAMOSONE (Drug) $58.54
- SKYRIZI (Biological) $53.38
- ZILXI (Drug) $47.03
- BRYHALI (Drug) $45.82
- HUMIRA (Biological) $42.58
- AKLIEF (Drug) $42.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.